Scholarlink

Background <p>Vitiligo is a&#xa0;common chronic disease leading to pigment cell loss in the skin. Despite international consensus recommendations on diagnosis and treatment and the German AWMF S1-guideline published in April 2021, no data exist on the adherence to these recommendations among German dermatologists in private practice. The aim of this pilot project and feasibility study was to obtain preliminary insight into the medical care situation provided by German dermatology practices to people with vitiligo.</p> Methods <p>In a&#xa0;cross-sectional observational study, we addressed 572&#xa0;dermatologists working in German private practices with a&#xa0;questionnaire on attitude, utilized diagnostic procedures, and prescription of reimbursable therapies.</p> Results <p>The majority (53.7%) considered vitiligo a&#xa0;cosmetic problem. Over half (51.1%) of the dermatologists did not use any of the diagnostic methods surveyed, and approximately a&#xa0;quarter (25.6%) did not use any of the therapies surveyed. Dermatologists who regard vitiligo as a&#xa0;serious disease use diagnostic procedures significantly more often and prescribe guideline-based therapies significantly more frequently than those who view vitiligo as a&#xa0;cosmetic issue.</p> Conclusion <p>Our cross-sectional observational and pilot study suggests a&#xa0;dramatic undertreatment of patients with vitiligo in private practices in Germany. Larger and more detailed studies are needed to confirm our preliminary data. In addition, measures that improve guideline-compliant therapy are required.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Versorgungssituation von Menschen mit Vitiligo

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2026年7月1日

查看全文
  • Larissa Mientus,
  • Rachel Sommer,
  • Kerstin Steinbrink,
  • Markus Böhm

摘要

Background

Vitiligo is a common chronic disease leading to pigment cell loss in the skin. Despite international consensus recommendations on diagnosis and treatment and the German AWMF S1-guideline published in April 2021, no data exist on the adherence to these recommendations among German dermatologists in private practice. The aim of this pilot project and feasibility study was to obtain preliminary insight into the medical care situation provided by German dermatology practices to people with vitiligo.

Methods

In a cross-sectional observational study, we addressed 572 dermatologists working in German private practices with a questionnaire on attitude, utilized diagnostic procedures, and prescription of reimbursable therapies.

Results

The majority (53.7%) considered vitiligo a cosmetic problem. Over half (51.1%) of the dermatologists did not use any of the diagnostic methods surveyed, and approximately a quarter (25.6%) did not use any of the therapies surveyed. Dermatologists who regard vitiligo as a serious disease use diagnostic procedures significantly more often and prescribe guideline-based therapies significantly more frequently than those who view vitiligo as a cosmetic issue.

Conclusion

Our cross-sectional observational and pilot study suggests a dramatic undertreatment of patients with vitiligo in private practices in Germany. Larger and more detailed studies are needed to confirm our preliminary data. In addition, measures that improve guideline-compliant therapy are required.